ATYR – atyr pharma, inc. (US:NASDAQ)
Stock Stats
News
aTyr Pharma, Inc. (NASDAQ:ATYR) is a favorite amongst institutional investors who own 57% [Yahoo! Finance]
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
Atyr PHARMA INC (NASDAQ: ATYR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis [Yahoo! Finance]
Form 424B5 aTYR PHARMA INC
Form 8-K aTYR PHARMA INC For: Dec 23
Form 4 aTYR PHARMA INC For: Dec 10 Filed by: BENEVICH ERIC
Form 3 aTYR PHARMA INC For: Dec 10 Filed by: BENEVICH ERIC
Form 8-K aTYR PHARMA INC For: Dec 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.